Related Experiment Videos
Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Robert M Smith1, Sandrine Lecour, Michael N Sack
1Hatter Institute for Cardiology Research, MRC Inter-University Cape Heart Group, University of Cape Town Medical School, South Africa.
Cardiovascular Research
|August 6, 2002
Summary
Innate immunity, involving cytokines, may promote heart cell survival during ischemia. Exploring these G(I)-protein independent pathways offers new cardioprotection strategies against heart damage.
Area of Science:
- Cardiology
- Immunology
- Cellular Biology
Background:
- Ischemic preconditioning protects the heart via G(I)-protein coupled receptor pathways.
- G(I)-protein coupled receptor independent pathways are crucial for novel cardioprotection strategies.
- The innate immune system's role in intrinsic cardioprotection against ischemia and viral myocarditis is emerging.
Purpose of the Study:
- To explore the role of innate immunity in ischemic preconditioning.
- To investigate G(I)-protein independent pathways in cardioprotection.
- To understand how cytokines mimic ischemic preconditioning effects.
Main Methods:
- Review of existing literature on innate immunity and cardioprotection.
- Analysis of studies demonstrating cytokine-induced mimicry of preconditioning.
- Postulation of mechanisms for innate immunity's role in cardioprotection.
Main Results:
- Cytokines like TNFalpha, IL-1beta, and leukemia inhibitory factor mimic ischemic preconditioning.
- Innate immunity utilizes diverse G(I)-protein independent receptors.
- The innate immune system is proposed as an integral component of ischemic preconditioning.
Conclusions:
- Innate immunity, through cytokine signaling, offers a G(I)-protein independent mechanism for cardioprotection.
- Understanding innate immune pathways can reveal novel therapeutic targets for ischemic heart disease.
- The innate immune system is a significant, yet understudied, contributor to ischemic preconditioning.